Am J Cardiovasc Drugs (2018) 18:117–127 https://doi.org/10.1007/s40256-017-0254-z ORIGINAL RESEARCH ARTICLE Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Signiﬁcant Coronary Artery Spasm: A Propensity Score Matching Study 1 1 2,3 2 • • • • Yong Hoon Kim Ae-Young Her Seung-Woon Rha Byoung Geol Choi 2 2 3 2,3 • • • • Se Yeon Choi Jae Kyeong Byun Ahmed Mashaly Yoonjee Park 3 3 3 3 • • • • Won Young Jang Woohyeun Kim Jah Yeon Choi Eun Jin Park 3 3 3 3 3 • • • • • Jin Oh Na Cheol Ung Choi Hong Euy Lim Eung Ju Kim Chang Gyu Park 3 3 Hong Seog Seo Dong Joo Oh Published online: 15 November 2017 Springer International Publishing AG 2017 Abstract Conclusions Additional long-term (5-year) treatment with Objective We aimed to evaluate the additive beneﬁt of trimetazidine in combination with diltiazem and nitrate in trimetazidine with well-known antispasmodic agents such patients with signiﬁcant CAS was not associated with as calcium channel blockers and nitrate in patients with improved clinical outcomes compared with combination signiﬁcant coronary artery spasm (CAS) as assessed by therapy with diltiazem and nitrate only (without acetylcholine provocation test
American Journal of Cardiovascular Drugs – Springer Journals
Published: Nov 15, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera